Franklin Resources’s Xeris Biopharma Holdings XERS Stock Holding History

Franklin Resources’s Portfolio XERS Stock Details XERS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$704K	Buy	88,885 +8,668	+11%	+$55.4K	﹤0.01%	2438
2026 Q1	$465K	Sell	80,217 -41,211	-34%	-$273K	﹤0.01%	2492
2025 Q4	$953K	Buy	121,428 +12,286	+11%	+$96.7K	﹤0.01%	2108
2025 Q3	$888K	Buy	109,142 +5,864	+6%	+$39K	﹤0.01%	2165
2025 Q2	$482K	Sell	103,278 -4,658	-4%	-$21.3K	﹤0.01%	2333
2025 Q1	$593K	Buy	107,936 +88,375	+452%	+$357K	﹤0.01%	2195
2024 Q4	$66.3K	Hold	19,561	–	–	﹤0.01%	2784
2024 Q3	$58.1K	Buy	19,561 +73	+0.4%	+$187	﹤0.01%	2789
2024 Q2	$43.8K	Buy	+19,488	New	+$39.3K	﹤0.01%	2741
2023 Q3	–	Sell	-63,703	Closed	-$167K	–	2797
2023 Q2	$167K	Buy	+63,703	New	+$162K	﹤0.01%	2430

Other funds holding XERS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Franklin Resources's XERS Position: Q2 2026 in Review

Franklin Resources increased its Xeris Biopharma Holdings (XERS) stake by 11% in Q2 2026, buying an estimated $55.4K and bringing the position to 88,885 shares worth $704K. The position accounts for ﹤0.01% of the portfolio, ranked #2438.

Franklin Resources first reported a position in XERS in Q2 2023 and has held it in 10 quarters since. The position peaked at $953K in Q4 2025. 241 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

Franklin Resources held 88,885 shares of Xeris Biopharma Holdings worth $704K as of Q2 2026.
Franklin Resources bought 8,668 Xeris Biopharma Holdings shares in Q2 2026, an estimated $55.4K.
Xeris Biopharma Holdings made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #2438 holding.
Franklin Resources first reported a position in Xeris Biopharma Holdings in Q2 2023 and has held it in 10 quarters since.
Franklin Resources's Xeris Biopharma Holdings position peaked at $953K in Q4 2025.
241 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.